PHARMACOKINETICS OF AMSACRINE IN PATIENTS RECEIVING COMBINED CHEMOTHERAPY FOR TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA

被引：19
|
作者：
JURLINA, JL
VARCOE, AR
PAXTON, JW
机构：
[1] UNIV AUCKLAND,SCH MED,DEPT PHARMACOL & CLIN PHARMACOL,AUCKLAND,NEW ZEALAND
[2] AUCKLAND HOSP,DEPT HAEMATOL,AUCKLAND,NEW ZEALAND
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1985年 / 14卷 / 01期
关键词：
D O I：
10.1007/BF00552719
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：21 / 25
页数：5
相关论文
共 50 条
  • [41] THE INNSZ-COOPERATIVE-GROUP - NONABLATIVE COMBINED CHEMOTHERAPY IN ADULT ACUTE MYELOGENOUS LEUKEMIA
    LOBATOMENDIZABAL, E
    RUIZARGUELLES, GJ
    LABARDINIMENDEZ, J
    GOMEZALMAGUER, D
    GANCICERRUD, G
    LOZANODELAVEGA, A
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1992, 44 (01): : 63 - 69
  • [42] A SPECIAL ROLE FOR AMSACRINE IN THE TREATMENT OF ACUTE-LEUKEMIA
    ARLIN, ZA
    CANCER INVESTIGATION, 1989, 7 (06) : 607 - 609
  • [43] Population Pharmacokinetics of Sorafenib in Acute Myelogenous/B-Type Leukemia Patients
    Liu, Tao
    Sabato, Philip
    Ivaturi, Vijay
    Greer, Jacqueline M.
    Pratz, Keith W.
    Smith, B. Douglas
    Rudek, Michelle A.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S68 - S68
  • [44] Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia
    Jorge Cortes
    Apostolia M. Tsimberidou
    Ricardo Alvarez
    Deborah Thomas
    Miloslav Beran
    Hagop Kantarjian
    Elihu Estey
    Francis J. Giles
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 497 - 500
  • [45] Acute myelogenous leukemia in a patient receiving etanercept for psoriasis
    Bachmeyer, Claude
    Thioliere, Brigitte
    Khosrotehrani, Kiarash
    Cattan, Elie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) : 169 - 170
  • [46] Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia
    Cortes, J
    Tsimberidou, AM
    Alvarez, R
    Thomas, D
    Beran, ML
    Kantarjian, H
    Estey, E
    Giles, FJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (06) : 497 - 500
  • [47] COMBINED THERAPY INTERFERON AND CHEMOTHERAPY IN CHRONIC MYELOGENOUS LEUKEMIA
    GUILHOT, F
    DREYFUS, B
    DESMAREST, MC
    GIRAUD, C
    HURET, JL
    BRIZARD, A
    TANZER, J
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1989, 31 (02): : 171 - 173
  • [48] MULTIPLE-DOSE PHARMACOKINETICS OF AN ORAL SOLUTION OF ITRACONAZOLE IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA
    PRENTICE, AG
    WARNOCK, DW
    JOHNSON, SAN
    TAYLOR, PC
    OLIVER, DA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (04) : 657 - 663
  • [49] ACUTE NONLYMPHOCYTIC LEUKEMIA IN PATIENTS RECEIVING CHEMOTHERAPY FOR NONMALIGNANT DISEASES
    SHEIBANI, K
    BUKOWSKI, RM
    TUBBS, RR
    SAVAGE, RA
    SEBEK, BA
    HOFFMAN, GC
    HUMAN PATHOLOGY, 1980, 11 (02) : 175 - 179
  • [50] Innovative approaches in the treatment and support of patients with acute myelogenous leukemia
    Rowe, Jacob M.
    ONCOLOGIST, 2007, 12 : 1 - 1
12345